In presenting this thesis or dissertation as a partial fulfillment of the requirements for an advanced degree from Emory Univers
Stindt, Maren (2012) Regulation of wild-type and mutant p53 activity. PhD thesis. http://theses.gla.ac.uk/3778/ Copyright and mo
An Arginine-rich Motif of Ring Finger Protein 4 (RNF4) Oversees the Recruitment and Degradation of the Phosphorylated and SUMOyl
![Pharmaceuticals | Free Full-Text | Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma | HTML Pharmaceuticals | Free Full-Text | Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-00626/article_deploy/html/images/pharmaceuticals-14-00626-ag.png)
Pharmaceuticals | Free Full-Text | Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma | HTML
An Arginine-rich Motif of Ring Finger Protein 4 (RNF4) Oversees the Recruitment and Degradation of the Phosphorylated and SUMOyl
![PDF) Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma PDF) Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma](https://i1.rgstatic.net/publication/352828470_Novel_Receptor_Tyrosine_Kinase_Pathway_Inhibitors_for_Targeted_Radionuclide_Therapy_of_Glioblastoma/links/60db61cea6fdccb745f4035a/largepreview.png)
PDF) Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma
![Pharmaceuticals | Free Full-Text | Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma | HTML Pharmaceuticals | Free Full-Text | Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-00626/article_deploy/html/images/pharmaceuticals-14-00626-g002.png)